google-site-verification=NjYuzjcWjJ9sY0pu2JmuCKlQLgHuwYq4L4hXzAk4Res Tryptophan and Sleep Disruptions in Patients With Celiac Disease - Basic and Clinical Neuroscience
Volume 16, Issue 3 (May & June 2025)                   BCN 2025, 16(3): 677-690 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Asri N, Ahmadi B, Taraghikhah N, Houri H, Jahani-Sherafat S, Rezaei-Tavirani M, et al . Tryptophan and Sleep Disruptions in Patients With Celiac Disease. BCN 2025; 16 (3) :677-690
URL: http://bcn.iums.ac.ir/article-1-2997-en.html
1- Student Research Committee, Celiac Disease and Gluten Related Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
2- Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
3- Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
4- Laser Application in Medical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
5- Proteomics Research Center, School of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
6- Department of Health and Community Medicine, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract:  
Introduction: Inflammatory responses in celiac disease (CD) may lead to immune dysregulation and sleep disturbance. Additionally, impaired tryptophan (Trp) metabolism in the gastrointestinal tract has been linked to chronic intestinal inflammation. This study aimed to investigate the relationship between sleep disorders, Trp levels, and cytokine profiles in patients with CD. 
Methods: A cohort study involving 76 adults with CD (mean age 40.3 years) was conducted from March to December 2022. Sleep quality was assessed using the Pittsburgh sleep quality index (PSQI) questionnaire. Plasma Trp levels were measured using high-performance liquid chromatography (HPLC), and serum tumor necrosis factor-alpha (TNF-α) and interleukin (IL)-10 levels were determined using enzyme-linked immunosorbent assay (ELISA). IL-2 and IL-4 expression was evaluated using quantitative real-time polymerase chain reaction (qPCR).
Results: A significant proportion (63.2%) of patients with CD experienced poor sleep quality. Additionally, increasing age was positively correlated with sleep disturbances. Importantly, patients with CD and poor sleep quality had lower plasma Trp levels than those with good sleep quality (P<0.0001). Moreover, individuals with poor sleep quality exhibited elevated IL-2 levels (P=0.03) compared to those with good sleep quality. Conversely, no significant difference was observed in IL-4, IL-10, and TNF-α levels between individuals with poor and good sleep quality. 
Conclusion: Low Trp levels may indicate the potential for Trp supplementation to alleviate sleep disturbances in patients with CD. However, further research is required to understand the underlying mechanisms and evaluate potential interventions.
Full-Text [PDF 916 kb]   |   |   Full-Text (HTML)   
Type of Study: Original | Subject: Behavioral Neuroscience
Received: 2024/08/10 | Accepted: 2024/09/14 | Published: 2025/05/1

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Basic and Clinical Neuroscience

Designed & Developed by : Yektaweb